863329-66-2Relevant articles and documents
Preparation method of intermediate
-
Paragraph 0030-0035; 0036-0039, (2021/09/08)
The invention relates to the field of pharmacy, in particular to a preparation method of an intermediate of a solovir intermediate (2 ’ R) -2 ’ - deoxidized -2 ’ -fluoro -2 ’ -methyl urea, and a compound represented by the formula II is reacted with triethylamine/methanol to generate a dehydroxylation protection reaction. By adopting the technical scheme disclosed by the invention, the total yield is high, the purity of the target product is high, the product stability is good, and the method is suitable for large-scale production. , Due to the fact that the adopted raw material cost is low, the process conditions are mild and non-rigorous, the method is easy to operate and easy to popularize.
Preparation method of sofosbuvir key intermediate
-
Paragraph 0013, (2020/05/01)
The invention belongs to the technical field of medicines, and particularly relates to a preparation method of a sofosbuvir key intermediate. The preparation method of the sofosbuvir intermediate hasthe advantages of short reaction steps, mild reaction conditions and higher yield than that of an existing preparation method, is economical and effective, and is suitable for large-scale industrial production.
Nucleoside phosphoramidate compound optical isomer and its application
-
Paragraph 0089; 0092-0093, (2018/07/30)
The invention belongs to the field of medicinal chemistry, and in particular relates to a nucleoside phosphoramidate compound optical isomer or its hydrate, solvate, crystal or a pharmaceutically acceptable salt, process for their preparation and pharmaceutical compositions containing these compounds and these compounds or compositions used as virus infectious disease treating drug use, in particular as viral hepatitis treatment drug use. The experimental result shows, the compounds of this invention to hepatitis c virus 1 b subtype and 1 a subtype exhibit good inhibitory activity, while at the same time to the host cell has very low toxicity, high effectiveness, the safety is good, suitable for the treatment and/or prevention of diseases associated with HCV infection.